Advent Hotels Promoter Pledge Released After Facility Repayment
"Advent Hotels Promoter Pledge Release: 21.70 Lakh Shares Released"
Advent Hotels Promoter Pledge Release Details
Sanjana Goenka, a member of Advent Hotels International's promoter group, released the pledge on 21,70,000 equity shares of the company. The shares represented 4.02% of the company's total share capital.
The pledge was released in two tranches. The first release involved 13,15,000 shares on August 18, 2026, followed by the release of 8,55,000 shares on August 19, 2026.
Advent Hotels Pledge Background
The shares were originally pledged in favour of IDBI Trusteeship Services Limited, acting on behalf of HDFC Limited.
The pledge was created in connection with a financial facility sanctioned to MIG (Bandra) Realtors & Builders Private Limited, a wholly owned subsidiary of Valor Estate Limited.
The company stated that the underlying financial facility has been fully repaid, resulting in the release of the pledge.
Advent Hotels Disclosure Clarification
The company also addressed a discrepancy in its earlier disclosure concerning the percentage of promoter and promoter group shareholding that was already encumbered.
Advent Hotels clarified that the corrected and ratified percentage of promoter and promoter group shareholding encumbered is 4.02% of the company's total share capital. The company attributed the earlier discrepancy to an inadvertent human error in reporting.
Advent Hotels Promoter Pledge Highlights
- Promoter Group Member: Sanjana Goenka
- Shares Released From Pledge: 21,70,000 equity shares
- Percentage of Total Share Capital: 4.02%
- First Release: 13,15,000 shares on August 18, 2026
- Second Release: 8,55,000 shares on August 19, 2026
- Pledgee: IDBI Trusteeship Services Limited, on behalf of HDFC Limited
- Underlying Facility: Facility sanctioned to MIG (Bandra) Realtors & Builders Private Limited
- Reason for Release: Full repayment of the underlying financial facility
- Corrected Encumbered Holding: 4.02% of total share capital
What to Watch Next
Investors may track further changes in promoter and promoter group shareholding or encumbrances.
They can monitor whether any additional shares are pledged or released in future disclosures.
Investors may also follow subsequent shareholding disclosures for any changes in the promoter group's holding.
Disclaimer
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)
Other News
Bajaj Nivesh Reports 9.7% Revenue Growth in Q2 FY27, Net Profit Rises 9.8%
Bajaj Nivesh Limited has reported its financial results for the quarter and half year ended September 30, 2026. The company recorded revenue from operations of Rs.297.36 crore in Q2 FY27, up 9.7% year-on-year (YoY). Net profit for the quarter stood at Rs.293.27 crore, while earnings per share increased to Rs.256.61 from Rs.233.69 in the corresponding quarter last year.
Balkrishna Industries Signs Strategic Partnership with Pirelli for Premium Car Tyres in India
Balkrishna Industries Limited (BKT) has signed a strategic agreement with Pirelli to expand its presence in India's premium passenger car tyre market. Under the agreement, BKT will produce up to 800,000 Pirelli-branded premium car tyres by 2030. Production will take place at one of BKT's newly constructed plants, equipped with advanced technology and designed to meet Pirelli's quality standards. The agreement also provides for a potential 50-50 joint venture to build a new production plant for high-value car tyres for domestic and international markets. The partnership aims to help both companies benefit from the expected growth in India's premium car tyre market.
Corona Remedies Receives ANVISA GMP Certification for Two Manufacturing Facilities
Corona Remedies Limited has received Good Manufacturing Practice (GMP) Compliance Certification from Brazil’s Health Regulatory Agency, ANVISA, for its Oral Solid Dosage (OSD) manufacturing facility and Hormone manufacturing facility, both located at Bhayla, Ahmedabad, Gujarat. The company disclosed the development to BSE Limited and the National Stock Exchange of India Limited on October 22, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The certification may support the company's efforts to expand its presence in international pharmaceutical markets, subject to applicable regulatory requirements.